⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
North Carolina's $10.8 Billion Life Sciences Boom Is Reshaping Research Triangle Industrial Real Estate
globenewswire.com
NVO
JNJ
AI-Enhanced Surgical Video Analytics Global Report 2025: Market to Expand by $1 Billion by 2034, Driven by Minimally Invasive Surgeries, Real-time Insights, Operating Rooms, and Cloud-based Platforms
globenewswire.com
JNJ
MDT
ISRG
Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study
prnewswire.com
JNJ
Fresenius Kabi Introduces New Presentation of Otulfi ® (ustekinumab-aauz), a Biosimilar to Stelara ®
businesswire.com
JNJ
FMS
Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma
globenewswire.com
JNJ
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report USA - English India - English
prnewswire.com
CLVT
LLY
GSK
JNJ
SNY
CELC
CRBP
BMY
Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval and Wider Commercialization Opportunity in nmCSPC Segment | DelveInsight
prnewswire.com
AZN
JNJ
PFE
ORGN
Marquis Who's Who Honors Marina Derosa as a Leader in Business Management
accessnewswire.com
JNJ
MRK
BP
Legal Bay Settlement Funding Reports Johnson & Johnson Hit with Almost $1 Billion in Trial Damages During Fourth Quarter of 2025
prnewswire.com
JNJ
Trends & Strategies Shaping the $7.5 Billion Sex Reassignment Surgery Market, 2025-2033
globenewswire.com
JNJ